---
title: "Medico Intercontinental Ltd (539938) — Share Price, Financials & Analysis"
symbol: "539938"
company: "Medico Intercontinental Ltd"
canonical: "https://tapetide.com/stocks/539938"
isin: "INE858Q01019"
nse_symbol: "MEDICOINTERCONTINENTALLTD"
bse_code: "539938"
sector: "Commercial Services"
industry: "Trading & Distributors"
market_cap_cr: 25.85
generated_at: "2026-09-13T18:28:09.611Z"
---

# Medico Intercontinental Ltd (539938)

Canonical page: https://tapetide.com/stocks/539938

## Company

- **NSE Symbol:** MEDICOINTERCONTINENTALLTD
- **BSE Code:** 539938
- **ISIN:** INE858Q01019
- **Sector:** Commercial Services
- **Industry:** Trading & Distributors
- **Macro Sector:** Services
- **Stock Type:** EQUITY
- **Listed Since:** 2019-06-21
- **CEO:** Mr. Samir Dilipkumar Shah
- **Employees:** 38
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** medicointercontinental.com

## About

Incorporated in 1914, Medico Intercontinental 
Ltd is engaged in trading of Pharmaceutical products[1]

## Latest Price

## Key Fundamentals

Observed at 2026-09-11T04:36:39.466519Z.

- **Market Cap:** ₹25.85 Cr
- **Classification:** Microcap
- **P/E (reported):** -2
- **EPS (TTM):** ₹-3.97
- **EPS (reported):** ₹4.01
- **Book Value:** ₹46.89
- **Price to Book:** 0.53
- **Dividend Yield:** 0.4%
- **ROE:** 10.4%
- **ROCE:** 12.65%
- **Debt to Equity:** 1.43
- **Revenue (yearly):** ₹84.08 Cr
- **Net Income:** ₹-11.23 Cr
- **EBITDA:** ₹2.97 Cr
- **52-Week High:** ₹43
- **52-Week Low:** ₹20.61
- **RSI (14):** 40.4

## Tapetide Score

- **Score:** 52 / 100
- **Score date:** 2026-09-04
- **Archetype:** Out of Favour
- **What it means:** Financially sound, yet the market is not rewarding it. Cases like this usually need a specific reason the pessimism is misplaced, and patience for that reason to play out.
- **Pillar profile:** Quality: Good · Valuation: Fair · Momentum: Falling
- **Percentile:** 56.6 (of 4473 scored stocks)
- **Confidence:** 93%
- **Data coverage:** 86%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 17.7 | 9% |
| growth | 33 | 9% |
| momentum | 31.89 | 12% |
| ownership | 57.67 | 24% |
| quality | 65.82 | 22% |
| valuation | 57.88 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Strengths

- Stock is trading at 0.54 times its book value
- Promoter holding has increased by 1.36% over last quarter.
- Company's working capital requirements have reduced from 122 days to 76.2 days

### Weaknesses

- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of 3.81% over past five years.
- Company has a low return on equity of 4.23% over last 3 years.
- Earnings include an other income of Rs.1.13 Cr.

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | -227.42% | 29.6% | -222.16% |
| ebitda margin growth | -135.29% | -61.8% | -59.86% | -51.12% |
| net income growth | -78.26% | -320.2% | -387.95% | -462.26% |
| revenue growth | -7.96% | -12.78% | 3% | 4% |
| roce | -690% | 0.32% | -1.02% | 18.99% |
| roe | 73.82% | 18.59% | 9.31% | -61.51% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 17.12 | 14.25 | 15.7 | 19.28 | 36.45 | 18.43 | 21.16 | 21.35 | 20.4 | 19.85 | 22.49 | 20.71 |
| Expenses | 15.81 | 12.76 | 14.15 | 17.64 | 33.74 | 16.52 | 19.22 | 20.67 | 21.28 | 18.26 | 20.88 | 21.4 |
| Operating Profit | 1.31 | 1.49 | 1.55 | 1.64 | 2.71 | 1.91 | 1.94 | 0.68 | -0.88 | 1.59 | 1.61 | -0.69 |
| OPM % | 7.65 | 10.46 | 9.87 | 8.51 | 7.43 | 10.36 | 9.17 | 3.19 | -4.31 | 8.01 | 7.16 | -3.33 |
| Other Income | 0.08 | 0.09 | 0.14 | 0.11 | 0.1 | 0.13 | 0.11 | 0.29 | 0.55 | 0.34 | 0.11 | 0.13 |
| Interest | 0.09 | 0.13 | 0.16 | 0.18 | 0.28 | 0.24 | 0.3 | 2.36 | 2.06 | 1.9 | 1.85 | 1.91 |
| Depreciation | 0.07 | 0.07 | 0.08 | 0.08 | 0.2 | 0.23 | 0.28 | 0.62 | 1.95 | 1.43 | 1.43 | 1.21 |
| Profit before tax | 1.23 | 1.38 | 1.45 | 1.49 | 2.33 | 1.57 | 1.47 | -2.01 | -4.34 | -1.4 | -1.56 | -3.68 |
| Tax % | 29.27 | 26.09 | 28.28 | 27.52 | 29.61 | 27.39 | 22.45 | 23.88 | 4.61 | 20 | 51.28 | 10.33 |
| Net Profit | 0.87 | 1.02 | 1.04 | 1.08 | 1.63 | 1.17 | 1.17 | -2.49 | -4.51 | -1.66 | -2.33 | -4.05 |
| EPS in Rs | 0.87 | 1.02 | 1.04 | 1.08 | 1.63 | 1.17 | 1.17 | -0.68 | -1.65 | -0.22 | -0.65 | -1.45 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 0 | 10 | 82 | 70 | 74 | 76 | 71 | 96 | 84 | 83 |
| Expenses | 0 | 9 | 78 | 65 | 69 | 71 | 66 | 88 | 81 | 82 |
| Operating Profit | 0 | 1 | 4 | 5 | 5 | 5 | 6 | 8 | 3 | 2 |
| OPM % | — | 7 | 5 | 7 | 7 | 7 | 8 | 9 | 3.5 | 1.9 |
| Other Income | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 1 |
| Interest | 0 | 0 | 1 | 1 | 1 | 1 | 0 | 1 | 8 | 8 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 5 | 6 |
| Profit before tax | 0 | 1 | 3 | 4 | 4 | 5 | 5 | 7 | -9 | -11 |
| Tax % | 40 | 27 | 26 | 27 | 27 | 27 | 27 | 28 | 19 | — |
| Net Profit | 0 | 1 | 2 | 3 | 3 | 4 | 4 | 5 | -11 | -13 |
| EPS in Rs | 0.09 | 2.28 | 7.26 | 7.94 | 9.54 | 3.61 | 3.95 | 5.06 | -3.2 | -3.97 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 3 | 0 | 0 | 0 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 3 | 3 | 3 | 3 | 3 | 10 | 10 | 10 | 10 |
| Reserves | 0 | 1 | 3 | 6 | 9 | 31 | 35 | 39 | 37 |
| Borrowings | 0 | 0 | 14 | 9 | 9 | 5 | 5 | 17 | 67 |
| Other Liabilities | 1 | 5 | 16 | 12 | 11 | 13 | 6 | 10 | 3 |
| Total Liabilities | 4 | 9 | 36 | 31 | 32 | 59 | 56 | 76 | 117 |
| Fixed Assets | 0 | 0 | 2 | 2 | 2 | 3 | 4 | 9 | 51 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 |
| Other Assets | 4 | 9 | 34 | 28 | 30 | 56 | 53 | 67 | 64 |
| Total Assets | 4 | 9 | 36 | 31 | 32 | 59 | 56 | 76 | 117 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 0 | 1 | -14 | 6 | 4 | -10 | 6 | -7 | 17 |
| Cash from Investing Activity | 0 | 0 | 0 | -1 | -1 | -5 | -9 | -2 | 2 |
| Cash from Financing Activity | 0 | 0 | 13 | -5 | -1 | 20 | 0 | 9 | -16 |
| Net Cash Flow | 0 | 1 | 0 | 0 | 1 | 5 | -3 | -1 | 4 |
| Free Cash Flow | 0 | 1 | -14 | 5 | 4 | -11 | 4 | -9 | 12 |
| CFO/OP | -6 | 171 | -200 | 138 | 100 | -167 | 118 | -63 | 635 |

### Ratios

| Item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | — | 237 | 101 | 94 | 84 | 157 | 119 | 125 | 119 |
| Inventory Days | 0 | 26 | 46 | 58 | 47 | 52 | 69 | 45 | 87 |
| Days Payable | — | 201 | 74 | 67 | 50 | 67 | 30 | 37 | 82 |
| Cash Conversion Cycle | — | 62 | 74 | 85 | 81 | 143 | 158 | 134 | 124 |
| Working Capital Days | — | 78 | 74 | 68 | 66 | 132 | 134 | 156 | 76 |
| ROCE % | — | 28 | 36 | 25 | 25 | 17 | 12 | 14 | -1 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 54.78% | 55.08% | 55.08% | 55.08% | 55.08% | 55.17% | 55.17% | 55.17% | 55.17% | 57.15% | 57.15% | 58.51% |
| FIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| DIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 39.64% | 39.4% | 39.71% | 39% | 39.72% | 39.35% | 39.51% | 39.47% | 38.89% | 34.86% | 34.9% | 35.38% |
| Others | 5.58% | 5.52% | 5.22% | 5.93% | 5.21% | 5.48% | 5.32% | 5.36% | 5.94% | 7.99% | 7.95% | 6.11% |
| No. of Shareholders | 1134 | 1119 | 3499 | 3465 | 3577 | 3759 | 3731 | 3696 | 3625 | 3575 | 3499 | 3489 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Sell
- **Buy / Neutral / Sell:** 0 / 7 / 12

### Moving Averages — summary: **Strong Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 25.61 | Sell |
| EMA (10) | 25.75 | Sell |
| SMA (20) | 26.8 | Sell |
| EMA (20) | 26.36 | Sell |
| SMA (50) | 26.9 | Sell |
| EMA (50) | 26.75 | Sell |
| SMA (100) | 25.93 | Sell |
| EMA (100) | 27.3 | Sell |
| SMA (200) | 29.51 | Sell |
| EMA (200) | 29.35 | Sell |

### Oscillators — summary: **Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 43.94 | Neutral |
| MACD (12,26,9) | -0.62 | Sell |
| Stochastic (14,3,3) | 36.05 | Neutral |
| ADX (14) | 20.63 | Neutral |
| Williams %R (14) | -59.21 | Neutral |
| ATR (14) | 2.5 | High Volatility |
| ROC (12) | -8.93 | Sell |
| Stoch RSI (14) | 40.34 | Neutral |
| UO (7,14,28) | 56.13 | Neutral |

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-09-07 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4e45761a-09ec-488c-80ce-22e6abbff959.pdf) |
| 2026-09-05 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a044e7b3-738c-4976-a7dc-2f0a737ee438.pdf) |
| 2026-09-05 | [Notice Of The 42Nd Annual General Meeting Of The Company.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=23bc64d6-ed5f-41db-bda6-abfd32c66eb1.pdf) |
| 2026-09-03 | [Intimation Of The Book Closure & Annual General Meeting](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b7b7d095-b64b-4e7c-bc6d-b8ca72a40100.pdf) |
| 2026-08-17 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7d5e500e-6a12-4aff-a0ea-cf8844275400.pdf) |
| 2026-08-14 | [Board Meeting Outcome for Compliances Of Regulation 30 33 And 42 Of SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=782caa03-03e8-4c86-b5de-b229443f07bf.pdf) |
| 2026-08-05 | [Board Meeting Intimation for Compliance Of Regulation 29 30 And 33 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fb9a7f15-f1e2-4350-894e-69a9289a6f31.pdf) |
| 2026-07-09 | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c1c18ca2-4658-4bff-a89c-41c93e588496.pdf) |
| 2026-06-29 | [Closure of Trading Window](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9ff02cbe-10c6-48fc-b2df-ecf26276446a.pdf) |
| 2026-06-25 | [Updates - Submission Of Disclosure Under Regulation 7(2) Read With Regulation 6(2) Of SEBI (Prohibition Of Insider Trading) Regulations 2015](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a215f5dc-ae94-4a08-ac24-e8fc8f0c9db3.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-08-14 | [Results - Quarter Ended 30 June 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4eed7768-a314-4b68-b410-80eb38f95ad8.pdf) |
| 2026-05-22 | [Results - Financial Year Ended March 31 2026.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c846139f-233c-4486-b7a3-aa6dce43b0fd.pdf) |
| 2026-02-14 | [Results - For The Quarter And Nine Months Ended December 31 2025.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bcfa0454-c7f2-43f4-8562-61510e5e9af3.pdf) |
| 2025-11-14 | [Results - Financial Results For The Quarter And Half Year Ended September 30 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b1eac36b-1284-4916-9eca-2694ca905c8b.pdf) |
| 2025-08-14 | [Results - Financial Results For The Quarter Ended 30/06/2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2fdcf435-b182-472d-b440-c8731b5d5b00.pdf) |
| 2025-05-30 | [Results - Financial Year Ended 31/03/2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=945348de-29c6-453c-a41f-7b536022d964.pdf) |
| 2025-02-14 | [Results - Quarter And Nine Months Ended December 31 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=585372a7-e0ea-4005-a918-31d625ba40c1.pdf) |
| 2024-11-14 | [Results - Financials Results For The Quarter And Half Year Ended 30Th September, 2024.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=866bfc38-85ff-459c-ad24-f98546a593d4.pdf) |
| 2024-08-13 | [Results - Financial Results Ended 30/06/2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2fccbac8-2e5f-4493-9d75-32c57931065d.pdf) |
| 2024-05-25 | [Results - Financial Year Ended 31 March 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=19fde68f-235e-4888-922d-0e774c394e21.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 8 Apr - Company states it is not classified as a large corporate under SEBI debt fundraising framework. | [Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A 8 Apr - Company states it is not classified as a large corporate under SEBI debt fundraising framework.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/d05e6ec9-05e4-4941-ae68-e87526d40dae.pdf) |
| 6 Feb - Members approved Manan Shah reappointment (12 Apr 2026–11 Apr 2031); salary up to Rs87,00,000 p.a., 7.5% commission; independent director regularized. | [Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot 6 Feb - Members approved Manan Shah reappointment (12 Apr 2026–11 Apr 2031); salary up to Rs87,00,000 p.a., 7.5% commission; independent director regularized.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/ae274e0a-67ef-4628-9c74-7c5dfdcf8095.pdf) |
| 6 Feb - Feb 6, 2026: Postal ballot passed—Akhila Agnihotri regularized; Manan Shah reappointed MD (96.39% assent). | [Shareholder Meeting / Postal Ballot-Scrutinizer"s Report 6 Feb - Feb 6, 2026: Postal ballot passed—Akhila Agnihotri regularized; Manan Shah reappointed MD (96.39% assent).](https://www.bseindia.com/xml-data/corpfiling/AttachHis/459a41e5-9f03-4d17-bb95-ff030bec3dbc.pdf) |
| 6 Feb - Copy of Newspaper Publication- Extract of Financial Results for the period ended 31st December, 2025. | [Announcement under Regulation 30 (LODR)-Newspaper Publication 6 Feb - Copy of Newspaper Publication- Extract of Financial Results for the period ended 31st December, 2025.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/e6289d1a-f739-42c2-a723-30e8fe510333.pdf) |
| 4 Feb - Board meeting on 14 Feb 2026 to approve unaudited Q3 and nine-month results ended Dec 31, 2025. | [Board Meeting Intimation for Board Meeting In Compliance Of Regulation 29, 30 And 33 Of The SEBI (LODR) Regulations, 2015. 4 Feb - Board meeting on 14 Feb 2026 to approve unaudited Q3 and nine-month results ended Dec 31, 2025.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/ac077d07-34af-4252-8624-04114de73226.pdf) |
| 2m - Of Credit Rating under Regulation 30 of SEBI (LODR) Regulation, 2015. | [Announcement under Regulation 30 (LODR)-Credit Rating 2m - Of Credit Rating under Regulation 30 of SEBI (LODR) Regulation, 2015.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/e46a0d08-5ab4-4576-9aca-7415db741d5c.pdf) |
| 16 Apr - FY2025-26 secretarial compliance report filed; no non-compliances, and BSE website observation was rectified. | [Compliances-Reg.24(A)-Annual Secretarial Compliance 16 Apr - FY2025-26 secretarial compliance report filed; no non-compliances, and BSE website observation was rectified.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/2c59367f-0476-4e45-9eb9-7c5c4c807a3f.pdf) |
| 14 Feb - Q3 and nine-month unaudited results to 31 Dec 2025: standalone revenue Rs1,354.44L, PAT Rs61.15L. | [Results - For The Quarter And Nine Months Ended December 31, 2025. 14 Feb - Q3 and nine-month unaudited results to 31 Dec 2025: standalone revenue Rs1,354.44L, PAT Rs61.15L.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/bcfa0454-c7f2-43f4-8562-61510e5e9af3.pdf) |
| 14 Feb - Board approved unaudited standalone and consolidated results to Dec 31, 2025; Q3 revenue Rs1,354.44 lakh; reviewed Feb 14, 2026. | [Board Meeting Outcome for Compliances Of Regulation 30 And 33 Of SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015 14 Feb - Board approved unaudited standalone and consolidated results to Dec 31, 2025; Q3 revenue Rs1,354.44 lakh; reviewed Feb 14, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/0cdc6c02-7ca7-433c-b044-e354acc6640e.pdf) |
| — | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 4 Apr](https://www.bseindia.com/xml-data/corpfiling/AttachHis/c3d81aef-57d9-4531-b65a-7b54e8c0e72c.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from nse | [Financial Year 2011 from nse](https://archives.nseindia.com/annual_reports/AR_ORIENTABRA_2010_2011_08092011032727.zip) |
| from bse | [Financial Year 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/86d309e4-1585-4e31-a7af-c80bc4fbca9f.pdf) |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/fa4dbec9-1285-4d12-a7ba-42beb7e4dc05.pdf) |
| from bse | [Financial Year 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/f8ae8186-f21c-4246-9d0f-19d1865bfd1e.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/06b36852-7b84-4043-bbf6-45903639d3bf.pdf) |
| from bse | [Financial Year 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/b961a9f9-1c06-4a8e-a621-c1eb712b0543.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/909bd19e-2ed8-4e97-8e7d-e075f6d70c27.pdf) |
| from bse | [Financial Year 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/504879/75887504879.pdf) |
| from bse | [Annual Report 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/539938/75882539938.pdf) |
| from bse | [Financial Year 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/504879/70347504879.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T18:28:09.611Z.